{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T14:09:15Z","timestamp":1792591755748,"version":"4.5.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Seroepidemiology has significant potential for uncovering the unreported burden of infectious diseases. However, for diseases without well-defined serological correlates of protection, natural immune boosting\u2014whereby pathogen exposure triggers a detectable immune response without causing a transmissible infection\u2014can complicate the interpretation of serosurveys. This issue is relevant to pertussis, a vaccine-preventable disease that remains a significant public health concern worldwide. Here, we aimed to evaluate the reliability of pertussis serosurveys using a transmission model that tracked the dynamics of pertussis infection, natural\u00a0immune boosting, and seroprevalence. By fitting this model to seroprevalence data from the late whole-cell pertussis vaccine era in six European countries, we estimated that protection against infection conferred by natural infection or vaccination was variable but lasted, on average, for several decades. We then predicted the positive predictive value (PPV) of seropositivity in serosurveys among adults across twelve countries that broadly captured transmission patterns worldwide. Overall, we predicted a low PPV across multiple scenarios, especially in adults aged\u00a020\u201339 years, where it typically dropped below 50%. Thus, although serosurveys are unquestionably useful for quantifying pertussis exposure levels, the common interpretation of seroprevalence as a measure of recent infections may lead to overestimating pertussis circulation and underestimating the impact of pertussis vaccines.<\/jats:p>","DOI":"10.1038\/s41467-025-64716-0","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T11:46:18Z","timestamp":1759751178000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Natural immune boosting biases pertussis infection estimates in seroprevalence studies"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9302-4858","authenticated-orcid":false,"given":"Matthieu","family":"Domenech de Cell\u00e8s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5421-8692","authenticated-orcid":false,"given":"Anabelle","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4774-7091","authenticated-orcid":false,"given":"Tine","family":"Dalby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7221-3801","authenticated-orcid":false,"given":"Pejman","family":"Rohani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"64716_CR1","doi-asserted-by":"crossref","unstructured":"Rohani, P. & Scarpino, S. Pertussis: Epidemiology, Immunology, and Evolution. (Oxford University Press, 2018).","DOI":"10.1093\/oso\/9780198811879.001.0001"},{"key":"64716_CR2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/00000441-195109000-00011","volume":"222","author":"JE Gordon","year":"1951","unstructured":"Gordon, J. E. & Hood, R. I. Whooping cough and its epidemiological anomalies. Am. J. Med. Sci. 222, 333\u2013361 (1951).","journal-title":"Am. J. Med. Sci."},{"key":"64716_CR3","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.epidem.2011.10.001","volume":"3","author":"P Rohani","year":"2011","unstructured":"Rohani, P. & Drake, J. M. The decline and resurgence of pertussis in the US. Epidemics 3, 183\u2013188 (2011).","journal-title":"Epidemics"},{"key":"64716_CR4","first-page":"1041","volume":"132","author":"P Varughese","year":"1985","unstructured":"Varughese, P. Incidence of pertussis in Canada. Can. Med. Assoc. J. 132, 1041\u20131042 (1985).","journal-title":"Can. Med. Assoc. J."},{"key":"64716_CR5","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/s41579-024-01064-8","volume":"22","author":"M Domenech de Cell\u00e8s","year":"2024","unstructured":"Domenech de Cell\u00e8s, M. & Rohani, P. Pertussis vaccines, epidemiology and evolution. Nat. Rev. Microbiol. 22, 722\u2013735 (2024).","journal-title":"Nat. Rev. Microbiol."},{"key":"64716_CR6","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.ijid.2020.04.081","volume":"96","author":"AJ Chitkara","year":"2020","unstructured":"Chitkara, A. J. et al. Pertussis vaccination in mixed markets: recommendations from the Global Pertussis Initiative. Int. J. Infect. Dis. 96, 482\u2013488 (2020).","journal-title":"Int. J. Infect. Dis."},{"key":"64716_CR7","doi-asserted-by":"crossref","unstructured":"WHO. Pertussis vaccines: WHO position paper, August 2015-Recommendations. Vaccine 34, 1423\u20131425 (2016).","DOI":"10.1016\/j.vaccine.2015.10.136"},{"key":"64716_CR8","unstructured":"Immunization and vaccine-preventable communicable diseases. https:\/\/www.who.int\/data\/gho\/data\/themes\/immunization."},{"key":"64716_CR9","doi-asserted-by":"publisher","unstructured":"Luo, Y. et al. Global, regional, and national burden of pertussis in children aged 0\u201314 years from 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021. Social Sci. Res. Netw. https:\/\/doi.org\/10.2139\/ssrn.4986351 (2024).","DOI":"10.2139\/ssrn.4986351"},{"key":"64716_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-12830-9","volume":"22","author":"E Tessier","year":"2022","unstructured":"Tessier, E. et al. Impact of the COVID\u221219 pandemic on Bordetella pertussis infections in England. BMC Public Health 22, 405 (2022).","journal-title":"BMC Public Health"},{"key":"64716_CR11","doi-asserted-by":"crossref","unstructured":"Matczak, S. et al. Association between the COVID\u221219 pandemic and pertussis derived from multiple nationwide data sources, France, 2013 to 2020. Euro. Surveill. 27, 2100933 (2022).","DOI":"10.2807\/1560-7917.ES.2022.27.25.2100933"},{"key":"64716_CR12","doi-asserted-by":"crossref","unstructured":"Bhatt, P., Strachan, J., Easton, M., Franklin, L. & Drewett, G. Effect of COVID\u221219 restrictions and border closures on vaccine preventable diseases in Victoria, Australia, 2020-2021. Commun. Dis. Intell. 46 (2022).","DOI":"10.33321\/cdi.2022.46.29"},{"key":"64716_CR13","unstructured":"Increase of pertussis cases in the EU\/EEA. (2024)."},{"key":"64716_CR14","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3390\/vaccines12121346","volume":"12","author":"LF Bricks","year":"2024","unstructured":"Bricks, L. F., Vargas-Zambrano, J. C. & Macina, D. Epidemiology of pertussis after the COVID-19 pandemic: Analysis of the factors involved in the resurgence of the disease in high-, middle-, and low-income countries. Vaccines 12, 1346 (2024).","journal-title":"Vaccines"},{"key":"64716_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-015-1324-y","volume":"15","author":"SA McDonald","year":"2015","unstructured":"McDonald, S. A. et al. An evidence synthesis approach to estimating the incidence of symptomatic pertussis infection in the Netherlands, 2005\u20132011. BMC Infect. Dis. 15, 1\u201311 (2015).","journal-title":"BMC Infect. Dis."},{"key":"64716_CR16","doi-asserted-by":"crossref","unstructured":"Gill, C. J. et al. Asymptomatic Bordetella pertussis infections in a longitudinal cohort of young African infants and their mothers. Elife 10, e65663 (2021).","DOI":"10.7554\/eLife.65663"},{"key":"64716_CR17","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3122\/jabfm.2017.03.160330","volume":"30","author":"MH Ebell","year":"2017","unstructured":"Ebell, M. H., Marchello, C. & Callahan, M. Clinical diagnosis of Bordetella pertussis infection: a systematic review. J. Am. Board Fam. Med. 30, 308\u2013319 (2017).","journal-title":"J. Am. Board Fam. Med."},{"key":"64716_CR18","first-page":"221","volume":"05","author":"RM Rossi-Foulkes","year":"2010","unstructured":"Rossi-Foulkes, R. M. et al. Pertussis knowledge gaps among physicians. J. Pediatr. Infect. Dis. 05, 221\u2013225 (2010).","journal-title":"J. Pediatr. Infect. Dis."},{"key":"64716_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0398-7620(06)76692-5","volume":"54","author":"H Trottier","year":"2006","unstructured":"Trottier, H., Carabin, H. & Philippe, P. Measles, pertussis, rubella and mumps completeness of reporting. Literature review of estimates for industrialized countries. Rev. Epidemiol. Sante Publique 54, 27\u201339 (2006).","journal-title":"Rev. Epidemiol. Sante Publique"},{"key":"64716_CR20","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1001\/jama.1992.03480030064038","volume":"267","author":"RW Sutter","year":"1992","unstructured":"Sutter, R. W. & Cochi, S. L. Pertussis hospitalizations and mortality in the United States, 1985-1988. Evaluation of the completeness of national reporting. JAMA 267, 386\u2013391 (1992).","journal-title":"JAMA"},{"key":"64716_CR21","first-page":"20140886","volume":"281","author":"CE Gunning","year":"2014","unstructured":"Gunning, C. E., Erhardt, E. & Wearing, H. J. Conserved patterns of incomplete reporting in pre-vaccine era childhood diseases. Proc. Biol. Sci. 281, 20140886 (2014).","journal-title":"Proc. Biol. Sci."},{"key":"64716_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/femspd\/ftv050","volume":"73","author":"A-M Barkoff","year":"2015","unstructured":"Barkoff, A.-M., Gr\u00f6ndahl-Yli-Hannuksela, K. & He, Q. Seroprevalence studies of pertussis: what have we learned from different immunized populations. Pathog. Dis. 73, ftv050 (2015).","journal-title":"Pathog. Dis."},{"key":"64716_CR23","unstructured":"World Health Organization. The Immunological Basis for Immunization Series: Module 4: Pertussis. (World Health Organization, 2017)."},{"key":"64716_CR24","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/aje\/kwu209","volume":"180","author":"MA Vink","year":"2014","unstructured":"Vink, M. A., Bootsma, M. C. J. & Wallinga, J. Serial intervals of respiratory infectious diseases: a systematic review and analysis. Am. J. Epidemiol. 180, 865\u2013875 (2014).","journal-title":"Am. J. Epidemiol."},{"key":"64716_CR25","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1086\/315527","volume":"181","author":"BP Mahon","year":"2000","unstructured":"Mahon, B. P., Brady, M. T. & Mills, K. H. Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children. J. Infect. Dis. 181, 2087\u20132091 (2000).","journal-title":"J. Infect. Dis."},{"key":"64716_CR26","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.epidem.2016.04.001","volume":"16","author":"PFM Teunis","year":"2016","unstructured":"Teunis, P. F. M., van Eijkeren, J. C. H., de Graaf, W. F., Marinovi\u0107, A. B. & Kretzschmar, M. E. E. Linking the seroresponse to infection to within-host heterogeneity in antibody production. Epidemics 16, 33\u201339 (2016).","journal-title":"Epidemics"},{"key":"64716_CR27","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/cid\/ciz840","volume":"71","author":"H Graaf","year":"2020","unstructured":"Graaf, H., de et al. Controlled Human Infection With Bordetella pertussis Induces Asymptomatic, Immunizing Colonization. Clin. Infect. Dis. 71, 403\u2013411 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"64716_CR28","doi-asserted-by":"crossref","unstructured":"Pertussis: adults, infants, and herds. Lancet 339, 526\u2013527 (1992).","DOI":"10.1016\/0140-6736(92)90343-2"},{"key":"64716_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1006\/biol.1997.0083","volume":"25","author":"PE Fine","year":"1997","unstructured":"Fine, P. E. Adult pertussis: a salesman\u2019s dream-and an epidemiologist\u2019s nightmare. Biologicals 25, 195\u2013198 (1997).","journal-title":"Biologicals"},{"key":"64716_CR30","doi-asserted-by":"crossref","unstructured":"Crowcroft, N. & Miller, E. Pertussis epidemiology. in Pertussis: Epidemiology, Immunology, and Evolution (eds. Rohani, P. & Scarpino, S.) 66\u201386 (Oxford University Press, 2019).","DOI":"10.1093\/oso\/9780198811879.003.0004"},{"key":"64716_CR31","doi-asserted-by":"publisher","first-page":"7259","DOI":"10.1073\/pnas.1014394108","volume":"108","author":"JS Lavine","year":"2011","unstructured":"Lavine, J. S., King, A. A. & Bj\u00f8rnstad, O. N. Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure. Proc. Natl. Acad. Sci. USA 108, 7259\u20137264 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"64716_CR32","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1016\/S0264-410X(03)00407-9","volume":"21","author":"J Storsaeter","year":"2003","unstructured":"Storsaeter, J., Hallander, H. O., Gustafsson, L. & Olin, P. Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis. Vaccine 21, 3542\u20133549 (2003).","journal-title":"Vaccine"},{"key":"64716_CR33","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/cid\/ciz821","volume":"71","author":"BC Liu","year":"2020","unstructured":"Liu, B. C. et al. Effectiveness of acellular pertussis vaccine in older adults: nested matched case-control Study. Clin. Infect. Dis. 71, 340\u2013350 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"64716_CR34","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268820002800","volume":"148","author":"SL Razafimahatratra","year":"2020","unstructured":"Razafimahatratra, S. L. et al. Seroprevalence of pertussis in Madagascar and implications for vaccination. Epidemiol. Infect. 148, e283 (2020).","journal-title":"Epidemiol. Infect."},{"key":"64716_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0303508","volume":"19","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. Seroepidemiology of pertussis in Huzhou: a population-based, cross-sectional study. PLoS One 19, e0303508 (2024).","journal-title":"PLoS One"},{"key":"64716_CR36","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3390\/vaccines10091511","volume":"10","author":"D Papagiannis","year":"2022","unstructured":"Papagiannis, D. et al. Pertussis prevalence in adult population in Greece: a seroprevalence nationwide study. Vaccines 10, 1511 (2022).","journal-title":"Vaccines"},{"key":"64716_CR37","doi-asserted-by":"publisher","first-page":"2331438","DOI":"10.1080\/21645515.2024.2331438","volume":"20","author":"X Sun","year":"2024","unstructured":"Sun, X. et al. The seroepidemiology of immunoglobulin G antibodies against pertussis toxin and filamentous hemagglutinin in the east of China during the COVID-19 pandemic. Hum. Vaccin. Immunother. 20, 2331438 (2024).","journal-title":"Hum. Vaccin. Immunother."},{"key":"64716_CR38","doi-asserted-by":"publisher","first-page":"1472157","DOI":"10.3389\/fimmu.2024.1472157","volume":"15","author":"EP Silva","year":"2024","unstructured":"Silva, E. P. et al. Seroprevalence study reveals pertussis underreporting in Brazil and calls for adolescent\/young adult boosting: mouse model demonstrates immunity restoration. Front. Immunol. 15, 1472157 (2024).","journal-title":"Front. Immunol."},{"key":"64716_CR39","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1016\/j.vaccine.2021.08.063","volume":"39","author":"G Echaniz-Aviles","year":"2021","unstructured":"Echaniz-Aviles, G. et al. Estimating Bordetella pertussis seroprevalence in adolescents and young adults in Mexico using the 2012 National Health and Nutrition Survey (ENSANUT). Vaccine 39, 5839\u20135844 (2021).","journal-title":"Vaccine"},{"key":"64716_CR40","doi-asserted-by":"publisher","first-page":"6956","DOI":"10.1016\/j.vaccine.2022.10.020","volume":"40","author":"H He","year":"2022","unstructured":"He, H. et al. The decline in immunity and circulation of pertussis among Chinese population during the COVID-19 pandemic: a cross-sectional sero-epidemiological study. Vaccine 40, 6956\u20136962 (2022).","journal-title":"Vaccine"},{"key":"64716_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1054617","volume":"10","author":"Q Chen","year":"2022","unstructured":"Chen, Q. et al. Seroepidemiology of pertussis in the east of China: Estimates of incidence of infection in adolescents and adults pre- and post-COVID-19. Front. Public Health 10, 1054617 (2022).","journal-title":"Front. Public Health"},{"key":"64716_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23114-y","volume":"12","author":"G Berbers","year":"2021","unstructured":"Berbers, G. et al. Circulation of pertussis and poor protection against diphtheria among middle-aged adults in 18 European countries. Nat. Commun. 12, 2871 (2021).","journal-title":"Nat. Commun."},{"key":"64716_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e39889","volume":"10","author":"N Wanlapakorn","year":"2024","unstructured":"Wanlapakorn, N. et al. Seroprevalence of antibodies against diphtheria, tetanus, and pertussis across various age groups during the post-COVID-19 pandemic period in Chonburi Province, Thailand. Heliyon 10, e39889 (2024).","journal-title":"Heliyon"},{"key":"64716_CR44","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1017\/S0950268804003012","volume":"133","author":"RG Pebody","year":"2005","unstructured":"Pebody, R. G. et al. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol. Infect. 133, 159\u2013171 (2005).","journal-title":"Epidemiol. Infect."},{"key":"64716_CR45","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/apm.13165","volume":"129","author":"L Wehlin","year":"2021","unstructured":"Wehlin, L. et al. Pertussis seroprevalence among adults of reproductive age (20-39 years) in fourteen European countries. APMIS 129, 556\u2013565 (2021).","journal-title":"APMIS"},{"key":"64716_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20544-y","volume":"12","author":"D Mistry","year":"2021","unstructured":"Mistry, D. et al. Inferring high-resolution human mixing patterns for disease modeling. Nat. Commun. 12, 323 (2021).","journal-title":"Nat. Commun."},{"key":"64716_CR47","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1017\/S1446181113000023","volume":"54","author":"MP Dafilis","year":"2012","unstructured":"Dafilis, M. P., Frascoli, F., Wood, J. G. & Mccaw, J. M. The influence of increasing life expectancy on the dynamics of sirs systems with immune boosting. ANZIAM J. Electron. Suppl. 54, 50\u201363 (2012).","journal-title":"ANZIAM J. Electron. Suppl."},{"key":"64716_CR48","doi-asserted-by":"publisher","first-page":"e14183","DOI":"10.1371\/journal.pone.0014183","volume":"5","author":"SC de Greeff","year":"2010","unstructured":"de Greeff, S. C. et al. Seroprevalence of pertussis in the Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS One 5, e14183 (2010).","journal-title":"PLoS One"},{"key":"64716_CR49","doi-asserted-by":"publisher","first-page":"e35874","DOI":"10.1371\/journal.pone.0035874","volume":"7","author":"P Campbell","year":"2012","unstructured":"Campbell, P. et al. Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia. PLoS One 7, e35874 (2012).","journal-title":"PLoS One"},{"key":"64716_CR50","doi-asserted-by":"publisher","first-page":"e1000647","DOI":"10.1371\/journal.ppat.1000647","volume":"5","author":"HJ Wearing","year":"2009","unstructured":"Wearing, H. J. & Rohani, P. Estimating the duration of pertussis immunity using epidemiological signatures. PLoS Pathog. 5, e1000647 (2009).","journal-title":"PLoS Pathog."},{"key":"64716_CR51","doi-asserted-by":"publisher","first-page":"e72086","DOI":"10.1371\/journal.pone.0072086","volume":"8","author":"JS Lavine","year":"2013","unstructured":"Lavine, J. S., King, A. A., Andreasen, V. & Bj\u00f8rnstad, O. N. Immune boosting explains regime-shifts in prevaccine-era pertussis dynamics. PLoS One 8, e72086 (2013).","journal-title":"PLoS One"},{"key":"64716_CR52","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1098\/rsif.2012.0432","volume":"9","author":"G Rozhnova","year":"2012","unstructured":"Rozhnova, G. & Nunes, A. Modelling the long-term dynamics of pre-vaccination pertussis. J. R. Soc. Interface 9, 2959\u20132970 (2012).","journal-title":"J. R. Soc. Interface"},{"key":"64716_CR53","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S0140-6736(99)04482-7","volume":"355","author":"P Rohani","year":"2000","unstructured":"Rohani, P., Earn, D. J. & Grenfell, B. T. Impact of immunisation on pertussis transmission in England and Wales. Lancet 355, 285\u2013286 (2000).","journal-title":"Lancet"},{"key":"64716_CR54","first-page":"3239","volume":"277","author":"H Broutin","year":"2010","unstructured":"Broutin, H., Viboud, C., Grenfell, B. T., Miller, M. A. & Rohani, P. Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries. Proc. Biol. Sci. 277, 3239\u20133245 (2010).","journal-title":"Proc. Biol. Sci."},{"key":"64716_CR55","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1016\/S0264-410X(03)00007-0","volume":"21","author":"M-P Pr\u00e9ziosi","year":"2003","unstructured":"Pr\u00e9ziosi, M.-P. & Halloran, M. E. Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness. Vaccine 21, 1853\u20131861 (2003).","journal-title":"Vaccine"},{"key":"64716_CR56","doi-asserted-by":"publisher","first-page":"9595","DOI":"10.1073\/pnas.1220908110","volume":"110","author":"JC Blackwood","year":"2013","unstructured":"Blackwood, J. C., Cummings, D. A. T., Broutin, H., Iamsirithaworn, S. & Rohani, P. Deciphering the impacts of vaccination and immunity on pertussis epidemiology in Thailand. Proc. Natl. Acad. Sci. Usa. 110, 9595\u20139600 (2013).","journal-title":"Proc. Natl. Acad. Sci. Usa."},{"key":"64716_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004138","volume":"11","author":"M Gambhir","year":"2015","unstructured":"Gambhir, M. et al. A change in vaccine efficacy and duration of protection explains recent rises in pertussis incidence in the United States. PLoS Comput. Biol. 11, e1004138 (2015).","journal-title":"PLoS Comput. Biol."},{"key":"64716_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2021.737870","volume":"2","author":"EE Lambert","year":"2021","unstructured":"Lambert, E. E. et al. Reduced Bordetella pertussis-specific CD4+ T-cell responses at older age. Front. Aging 2, 737870 (2021).","journal-title":"Front. Aging"},{"key":"64716_CR59","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/22221751.2018.1564630","volume":"8","author":"MM Wilk","year":"2019","unstructured":"Wilk, M. M. et al. Immunization with whole cell but not acellular pertussis vaccines primes CD4 TRM cells that sustain protective immunity against nasal colonization with Bordetella pertussis. Emerg. Microbes Infect. 8, 169\u2013185 (2019).","journal-title":"Emerg. Microbes Infect."},{"key":"64716_CR60","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1073\/pnas.1314688110","volume":"111","author":"JM Warfel","year":"2014","unstructured":"Warfel, J. M., Zimmerman, L. I. & Merkel, T. J. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc. Natl. Acad. Sci. USA 111, 787\u2013792 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"64716_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1046\/j.1365-2567.1998.00401.x","volume":"93","author":"M Ryan","year":"1998","unstructured":"Ryan, M. et al. Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children. Immunology 93, 1\u201310 (1998).","journal-title":"Immunology"},{"key":"64716_CR62","doi-asserted-by":"crossref","unstructured":"Eberhardt, C. S. & Siegrist, C.-A. What is wrong with pertussis vaccine immunity? Inducing and recalling vaccine-specific immunity. Cold Spring Harb. Perspect. Biol. 9, a029629 (2017).","DOI":"10.1101\/cshperspect.a029629"},{"key":"64716_CR63","doi-asserted-by":"crossref","unstructured":"Domenech de Cell\u00e8s, M., Magpantay, F. M. G., King, A. A. & Rohani, P. The pertussis enigma: reconciling epidemiology, immunology and evolution. Proc. Biol. Sci. 283, 20152309 (2016).","DOI":"10.1098\/rspb.2015.2309"},{"key":"64716_CR64","doi-asserted-by":"crossref","unstructured":"Domenech de Cell\u00e8s, M., Magpantay, F. M. G., King, A. A. & Rohani, P. The impact of past vaccination coverage and immunity on pertussis resurgence. Sci. Transl. Med. 10 (2018).","DOI":"10.1126\/scitranslmed.aaj1748"},{"key":"64716_CR65","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/jamapediatrics.2019.0711","volume":"173","author":"M Domenech de Cell\u00e8s","year":"2019","unstructured":"Domenech de Cell\u00e8s, M., Rohani, P. & King, A. A. Duration of immunity and effectiveness of diphtheria-tetanus-acellular pertussis vaccines in children. JAMA Pediatr. 173, 588\u2013594 (2019).","journal-title":"JAMA Pediatr."},{"key":"64716_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0197970","volume":"13","author":"A Chit","year":"2018","unstructured":"Chit, A. et al. Acellular pertussis vaccines effectiveness over time: a systematic review, meta-analysis and modeling study. PLoS One 13, e0197970 (2018).","journal-title":"PLoS One"},{"key":"64716_CR67","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1017\/S095026880600625X","volume":"134","author":"M Cagney","year":"2006","unstructured":"Cagney, M., MacIntyre, C. R., McIntyre, P., Puech, M. & Giammanco, A. The seroepidemiology of pertussis in Australia during an epidemic period. Epidemiol. Infect. 134, 1208\u20131216 (2006).","journal-title":"Epidemiol. Infect."},{"key":"64716_CR68","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1016\/j.vaccine.2010.02.104","volume":"28","author":"P Rendi-Wagner","year":"2010","unstructured":"Rendi-Wagner, P. et al. The seroepidemiology of Bordetella pertussis in Israel-Estimate of incidence of infection. Vaccine 28, 3285\u20133290 (2010).","journal-title":"Vaccine"},{"key":"64716_CR69","doi-asserted-by":"publisher","first-page":"e0155949","DOI":"10.1371\/journal.pone.0155949","volume":"11","author":"U Heininger","year":"2016","unstructured":"Heininger, U. et al. Comparative epidemiologic characteristics of pertussis in 10 Central and Eastern European countries, 2000-2013. PLoS One 11, e0155949 (2016).","journal-title":"PLoS One"},{"key":"64716_CR70","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/S0140-6736(16)30164-7","volume":"388","author":"CJE Metcalf","year":"2016","unstructured":"Metcalf, C. J. E. et al. Use of serological surveys to generate key insights into the changing global landscape of infectious disease. Lancet 388, 728\u2013730 (2016).","journal-title":"Lancet"},{"key":"64716_CR71","doi-asserted-by":"crossref","unstructured":"Mina, M. J. et al. A Global lmmunological Observatory to meet a time of pandemics. Elife 9, e58989 (2020).","DOI":"10.7554\/eLife.58989"},{"key":"64716_CR72","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3390\/pathogens11070732","volume":"11","author":"AH Haselbeck","year":"2022","unstructured":"Haselbeck, A. H. et al. Serology as a tool to assess infectious disease landscapes and guide public health policy. Pathogens 11, 732 (2022).","journal-title":"Pathogens"},{"key":"64716_CR73","unstructured":"WHO immunological basis for immunization series: module 7: measles: update 2020. https:\/\/www.who.int\/publications\/i\/item\/9789241516655 (2020)."},{"key":"64716_CR74","unstructured":"World Health Organization. The Immunological Basis for Immunization Series: Module 16: Mumps. (World Health Organization, 2020)."},{"key":"64716_CR75","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10096-010-1104-y","volume":"30","author":"N Guiso","year":"2011","unstructured":"Guiso, N. et al. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur. J. Clin. Microbiol. Infect. Dis. 30, 307\u2013312 (2011).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"64716_CR76","doi-asserted-by":"crossref","unstructured":"Pawitan, Y. In All Likelihood: Statistical Modelling and Inference Using Likelihood. (OUP Oxford, 2001).","DOI":"10.1093\/oso\/9780198507659.001.0001"},{"key":"64716_CR77","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1098\/rsif.2009.0386","volume":"7","author":"O Diekmann","year":"2010","unstructured":"Diekmann, O., Heesterbeek, J. A. P. & Roberts, M. G. The construction of next-generation matrices for compartmental epidemic models. J. R. Soc. Interface 7, 873\u2013885 (2010).","journal-title":"J. R. Soc. Interface"},{"key":"64716_CR78","unstructured":"Kassambara, A. Practical Guide to Cluster Analysis in R: Unsupervised Machine Learning. Vol. 1 (Sthda, 2017)."},{"key":"64716_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v069.i12","volume":"69","author":"AA King","year":"2016","unstructured":"King, A. A., Nguyen, D. & Ionides, E. L. Statistical Inference for Partially Observed Markov Processes via the R Package pomp. J. Stat. Softw. 69, 1\u201343 (2016).","journal-title":"J. Stat. Softw."},{"key":"64716_CR80","unstructured":"King, A. A. et al. pomp: Statistical Inference for Partially Observed Markov Processes. https:\/\/kingaa.github.io\/pomp\/ (2023)."},{"key":"64716_CR81","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. https:\/\/www.R-project.org\/ (2024)."},{"key":"64716_CR82","doi-asserted-by":"crossref","unstructured":"Brock, G., Pihur, V., Datta, S. & Datta, S. clValid: An R Package for Cluster Validation. J. Stat. Softw. 25, 1\u201322 (2008).","DOI":"10.18637\/jss.v025.i04"},{"key":"64716_CR83","unstructured":"Kassambara, A. & Mundt, F. Factoextra: Extract and Visualize the Results of Multivariate Data Analyses. http:\/\/www.sthda.com\/english\/rpkgs\/factoextra (2020)."},{"key":"64716_CR84","doi-asserted-by":"publisher","unstructured":"Domenech de Cell\u00e8s, M. & DomenechLab. DomenechLab\/Pertussis_seroprevalence: Accepter Paper Code: Natural Immune Boosting Biases Pertussis Infection Estimates in Seroprevalence Studies. https:\/\/doi.org\/10.5281\/ZENODO.17047292 (Zenodo, 2025).","DOI":"10.5281\/ZENODO.17047292"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64716-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64716-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64716-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:04:01Z","timestamp":1760141041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-64716-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["64716"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-64716-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,6]]},"assertion":[{"value":"3 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.R. received funding from Sanofi for a research project on pertussis vaccines. A.W. received consulting fees from Vaxcyte for work unrelated to pertussis. All other authors declare no competing interests related to this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8883"}}